Full Text
EE470 Cost-Effectiveness Analysis of Rivaroxaban for Treatment of Stroke Prevention in Atrial Fibrillation

Abstract

Authors

M Kurnaz T Buyukisik S Okcun O Seyhun

Back to Volume 27, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×